МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ РФ СИБИРСКИЙ ...

188
109. Bellas R.E., Lee J.S., Sonenshein G. E. Expression of constitutive NF-
kB-like activity is essential for proliferation of cultured bovine vascular
smooth muscle cells// J.Clin. Invest.-1995.-Vol.96.-P. 2421-2530.
110. Bevan R.D. Effect of sympathetic denervation on smooth muscle cell
proliferation in the growing rabbit ear artery. Circ Res 1975; 37:14-9.
111. Biegelsen E.S., Loscalso J. Endotelial function and atherosclerosis.
Coron Artery Dis, 1999, Vol. 10, №.4. P.241-256.
112. Blann A., Seigneur M. Soluble markers of endothelial cell function. Clin.
Haemorheol. Microcirc., 1997,17(1):3-11.
113. Brilla C.G., Мurphy R.R. The concept of cardioreparation: Part 1.
Pathophysiology of remodelling // J. cardiovasc. Risk. – 1996. – Vol. 3. – P.
281-285.
114. Bulpitt C.J., Hodes C., Everitt M.C. The relationship between blood
pressure and biochemical risk factors in a general population // Brit.J.Prev.
Soc. Med.-1976.-Vol. 30-P.158-160.
115. Cabrera C., Bohr D. The role of nitric oxide in the central control of
blood pressures// Biochim. Biophys/ Res . Commun. 1995. Vol. 206. P. 77-81.
116. Caradente F., Ahlgren A., Halberg F. Mesor-hypertension: hints by
chronobiologists// Chronobiologia.-1984.-V.11.-№3/-P.189-203.
117. Casinmos Chr., Alvaris V., Varlamis G. et al.Arterial blood pressure
serum lipids and cardiovascular complications in families of hypertensive
children //Acta paediatr. Scand.-1982.-V.78.-№2.-P.235-238.
118. Celis H., Staessen J.A., Thijis L. et al. Cardiovascular risk in white- coat
and sustained hypertensive patients. J. of Hypertension Vol. 20 (Suppl.4), June
2002, P.S256 .
119. Chen II , Prewitt R., Dowell R. Microvascular rarefaction and tissue
vascular resistance in hypertension. Am J Physiol 1989;256:H 126-31.
120. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the
Joint National Committee on Prevention, Detection, Evaluation, and Treatment